Pre-Announced Drug Inspections To Continue At District Offices' Discretion
This article was originally published in The Tan Sheet
Executive Summary
FDA's pre-announced inspection program for drugs will continue at the discretion of district office management, a notice in the Jan. 4 Federal Register states.
You may also be interested in...
FDA inspections
Pre-announced inspection program receives "high marks" from CHPA members and has "helped streamline routine inspections and...enhanced the goodwill and cooperation of FDA and industry," trade association says in Oct. 30 letter urging agency's Office of Regulatory Affairs to retain the program for drug manufacturing facilities. FDA expanded the system from devices to drugs and biologics in 1999 as a three-faceted pilot program - pre-announced inspections, annotated 483 inspection reports and formal notification of positive inspection results. ORA currently is evaluating the program's status as part of its resource utilization review, the agency says
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands